Larimar Therapeutics, Inc. (LRMR): Net Income
-$165.67M
Year ended 2025-12-31
-$172.60M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$165.67M | n/m | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | -$80.60M | n/m | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | -$36.95M | n/m | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | -$35.35M | n/m | 2024-03-14, From 2022-01-01 |
| 2021-12-31 | -$50.64M | n/m | 2023-03-14, From 2021-01-01 |
| 2020-12-31 | -$42.48M | n/m | 2022-03-25, From 2020-01-01 |
| 2019-12-31 | -$23.13M | n/c | 2021-03-04, From 2019-01-01 |
| 2018-12-31 | -$61.37M | n/m | 2020-03-05, From 2018-01-01 |
| 2017-12-31 | -$52.03M | n/m | 2020-03-05, From 2017-01-01 |
| 2016-12-31 | -$57.88M | n/m | 2019-03-14, From 2016-01-01 |
| 2015-12-31 | -$74.29M | n/m | 2018-03-09, From 2015-01-01 |
| 2014-12-31 | -$36.48M | n/m | 2017-03-10, From 2014-01-01 |
| 2013-12-31 | -$14.03M | n/m | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | -$13.88M | n/a | 2015-03-25, From 2012-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Larimar Therapeutics, Inc. (LRMR) | 2025-12-31 | -$165.67M | n/m |
| XBiotech Inc. (XBIT) | 2025-12-31 | -$45.54M | n/m |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | -$99.50M | n/m |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | -$20.60M | n/m |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | -$17.41M | n/m |
| Monopar Therapeutics (MNPR) | 2025-12-31 | -$13.72M | n/m |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | -$17.37M | n/m |
| Veradermics, Inc (MANE) | 2025-12-31 | -$70.00M | n/m |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $44.87M | n/m |
Compare LRMR, XBIT, PRLD, WHWK side by side · Screen every company in Pharmaceutical Preparations ↗